Pages that link to "Q59091780"
Jump to navigation
Jump to search
The following pages link to Cancer biology: Heritable fragile sites in cancer (Q59091780):
Displaying 50 items.
- Nucleotide sequence of a functional cDNA for human thymidylate synthase (Q24294732) (← links)
- The replication fork: understanding the eukaryotic replication machinery and the challenges to genome duplication (Q24633729) (← links)
- FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites (Q28291193) (← links)
- Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia (Q28305775) (← links)
- Syndrome-related chromosome-specific radiation-induced break points of various inherited human metabolic disorders (Q30955354) (← links)
- Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma (Q31913764) (← links)
- Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer (Q33682080) (← links)
- Translocation (12;17)(q13;q23) in de novo acute myeloid leukemia with trilineage myelodysplasia (Q33767007) (← links)
- Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia (Q33910459) (← links)
- The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors (Q34804028) (← links)
- Genotoxicity of pesticides: a review of human biomonitoring studies (Q35145900) (← links)
- Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. (Q35195363) (← links)
- Induction of sister chromatid exchanges at common fragile sites (Q35199532) (← links)
- Chromosome breakage and recombination at fragile sites (Q35246834) (← links)
- Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. (Q35249770) (← links)
- Chromosomal instability in oral cancer cells. (Q36019105) (← links)
- A new rare distamycin A-inducible fragile site, fra(11) (p15.1), found in two acute nonlymphocytic leukemia (ANLL) patients with t(7;11)(p15-p13;p15). (Q36436223) (← links)
- Population cytogenetics of rare fragile sites in Japan (Q36449125) (← links)
- Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia (Q36620133) (← links)
- Chromosomal fragile sites (Q36705741) (← links)
- Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome (Q36823287) (← links)
- Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells (Q36903694) (← links)
- Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication (Q37297007) (← links)
- Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation (Q37551935) (← links)
- Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites (Q37559058) (← links)
- Cytogenetics meets phylogenetics: a review of karyotype evolution in diprotodontian marsupials (Q37767961) (← links)
- Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors (Q38495093) (← links)
- Genome position and gene amplification (Q38606305) (← links)
- Genetic predisposition to cancer with special reference to mutagen sensitivity (Q39670052) (← links)
- Is spontaneous mutation the major 'cause' of childhood acute lymphoblastic leukaemia? (Q39743034) (← links)
- Chromosomal changes in secondary leukemias of childhood and young adulthood (Q39745164) (← links)
- Associations between morphology, karyotype, and clinical features in myeloid leukemias. (Q39758339) (← links)
- An appraisal of the application of recombinant DNA techniques to chromosome defects (Q39816011) (← links)
- Fragile sites on human chromosomes: description and clinical significance (Q39827865) (← links)
- Induction, by thymidylate stress, of genetic recombination as evidenced by deletion of a transferred genetic marker in mouse FM3A cells (Q40667337) (← links)
- Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. (Q40890859) (← links)
- Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons (Q41115353) (← links)
- Multiple common fragile sites are expressed in the genome of the laboratory rat. (Q41357230) (← links)
- Alpha-interferon and fragility at 16q22. A study on 15 selected controls and 146 selected patients (Q41478888) (← links)
- Cosegregation of hypertrophic cardiomyopathy and a fragile site on chromosome 16 in a large Italian family (Q41673863) (← links)
- An FHIT tumor suppressor gene? (Q41749103) (← links)
- Different inducibility and possible significance of several concomitant "fragile sites" in two brothers (Q41868013) (← links)
- Induction of the common fragile site FRA3B does not affect FHIT expression (Q43583324) (← links)
- A distamycin A-inducible fragile site, FRA8E, located in the region of the hereditary multiple exostoses gene, is not involved in HPV16 DNA integration and amplification (Q43743836) (← links)
- Expression of fragile sites in childhood acute lymphoblastic leukemia patients and normal controls (Q43825284) (← links)
- FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival (Q43938159) (← links)
- Telomere association of chromosomes induced by aphidicolin in a normal individual (Q44852661) (← links)
- Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures (Q45075516) (← links)
- The fragile site (16) (q22). I. Induction by AT-specific DNA-ligands and population frequency (Q45103331) (← links)
- No difference in expression of chromosomal fragile sites in patients with solid malignant tumours and normal controls. (Q52866075) (← links)